 Home > Active Ingredient News > Immunology News > Lancet Rheumato: Vulnerable to autoimmune rheumatoid diseases for new crown pneumonia

Lancet Rheumato: Vulnerable to autoimmune rheumatoid diseases for new crown pneumonia

 Last Update: 2020-07-14
 Source: Internet
 Author: User

Tags

new china martinsburg

gamma 1 2

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, researchers examined the COVID-19 susceptibility of auto
immuno
rheumatism disease in patients with theCOVID-19 pandemicresearchers conducted a multi-center retrospective study of patients with autoimmune rheumatism disease in Hubei Province, the epicenter of the COVID-19 outbreak in ChinaThrough an automated telephone-based survey, patients with rheumatism were contacted to investigate their COVID-19 susceptibilitycollected data on 6,228 patients with autoimmune rheumatoid diseases between March 20 and March 30, 2020In the study population, the total incidence of COVID-19 in patients with autoimmune rheumatism was 0.43% (27 out of 6228)The researchers identified 42 families diagnosedthe COVID-19 outbreak between December 20, 2019 and March 20, 2020, and whose members were either people with rheumatic disease or family members who lived in the same location during the outbreakOf these 42 families, 27 (63%) of 43 patients with rheumatic diseases and 28 (34%) of family members of 83 non-rheumatic diseases were diagnosed with COVID-19 (adjusted advantage ratio of 2.68Patients with rheumatoid diseases taking hydroxychloroquinethe risk of infectionCOVID-19 is lower than in patients taking other anti-rheumatic drugs (OR:0.09)In addition, the risk of COVID-19 increases with age (corrected OR: 1.04) study that patients with autoimmune rheumatoid diseases are susceptible to the of new coronapneumonia

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Purity 99% BPN14770 Zatolmilast 1606974-33-7 In Stock Fast Ship to USA

CAS No.: 1606974-33-7

Pharm Grade

$1-1.1/UNIT FOB

High quality Thymosin α1 Pure CAS 62304-98-7 Thymosin Alpha 1 Thymalfasin

CAS No.: 62304-98-7

Pharmacy Grade

$12-15/UNIT FOB

Top quantity Imiquimod CAS NO 99011-02-6 White crystalline powder 99% API

CAS No.: 99011-02-6

Pharmacy Grade

$1800-1850/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.